PTC Therapeutics, Inc. PTCT

Set alert

Price alert · PTCT

All alert types
60.88 USD +0.91 +1.52%

At close

62.10 +1.22 +2.00%

Pre-market · Nov 3, 7:00 AM ET

Bid
60.81 × 2
Ask
60.86 × 2
59.16 Day range 62.16
58.80 52-week range 90.87
YTD
-19.85%
1 year
-10.38%
Open
61.05
Prev close
59.97
Mkt cap
5.09B
Vol
1.34M
Avg vol
1.06M
EPS
-1.47
P/E
0.00
Div yield
0.00%
More statistics
Low
59.16
High
62.16
Forward P/E
25.05
Beta
0.51
Short ratio
6.38
Inst. own
122.68%
Dividend
0.00
Ex-div date
Earnings
Feb 18, 2027
50-d avg
65.36
200-d avg
70.67
1y target
100.40

3M chart

Chart tools
Interval

Events in this range
  • Sep 22, 2026Rating: Cantor Fitzgerald · Overweight → Overweight
  • Oct 8, 2026Rating: RBC Capital · Sector Perform → Sector Perform
  • Oct 29, 2026Earnings: -0.62; estimate 0.1434; surprise -532.36%
  • Oct 30, 2026Rating: Wells Fargo · Overweight → Overweight
  • Oct 30, 2026Rating: RBC Capital · Sector Perform → Sector Perform
  • Oct 30, 2026Rating: TD Cowen · Buy → Buy
  • Nov 2, 2026Rating: Citigroup · Buy → Buy
Signals (7)
NameDateAgo
SMA: BearishOct 30, 20263 days ago
SMA: BullishOct 29, 20264 days ago
MACD: Buy SignalOct 20, 20261 week ago
MACD: Sell SignalOct 13, 20262 weeks ago
MACD: Buy SignalSep 29, 20261 month ago
MACD: Sell SignalSep 8, 20261 month ago
MACD: Buy SignalAug 12, 20262 months ago

Analyst view

Consensus: buy

Buy
Price target (mean) 100.40 +64.9% upside
Target (low)
62.00
Target (mean)
100.40
Target (high)
137.00
Ratings (0m) 15 13 buy · 2 hold · 0 sell
  • Strong buy4
  • Buy9
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 15
  • 1 month ago 14
  • 2 months ago 14

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PTCT analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.140.13 – 0.15-1.80+107.8%329.54M+100.1%2
Next quarter0.35457-0.20 – 1.38-0.03+1281.9%313.41M+15.0%7
Current year0.9350.73 – 1.147.62-87.7%1.32B-23.9%2
Next year2.431.82 – 3.040.935+159.9%1.42B+8.2%2

Upgrades and downgrades

The latest rating changes

PTCT analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2026CitigroupMaintainedBuyBuy
Oct 30, 2026TD CowenMaintainedBuyBuy
Oct 30, 2026RBC CapitalMaintainedSector PerformSector Perform
Oct 30, 2026Wells FargoMaintainedOverweightOverweight
Oct 8, 2026RBC CapitalMaintainedSector PerformSector Perform
Sep 22, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Aug 14, 2026BarclaysMaintainedOverweightOverweight
Aug 13, 2026Wells FargoMaintainedOverweightOverweight
Jul 31, 2026Morgan StanleyMaintainedOverweightOverweight
Jul 31, 2026Wells FargoMaintainedOverweightOverweight
Jul 20, 2026Wells FargoMaintainedOverweightOverweight
Jul 16, 2026Cantor FitzgeraldMaintainedOverweightOverweight
Jul 7, 2026RBC CapitalMaintainedSector PerformSector Perform
May 27, 2026JefferiesUpgradeHoldBuy
May 8, 2026TD CowenUpgradeHoldBuy
May 8, 2026RBC CapitalMaintainedSector PerformSector Perform
May 8, 2026Wells FargoMaintainedOverweightOverweight
Mar 30, 2026JefferiesDowngradeBuyHold
Feb 23, 2026Morgan StanleyMaintainedOverweightOverweight
Feb 20, 2026Wells FargoMaintainedOverweightOverweight
Feb 20, 2026RBC CapitalMaintainedSector PerformSector Perform
Feb 20, 2026B of A SecuritiesMaintainedBuyBuy
Jan 28, 2026BarclaysUpgradeEqual-WeightOverweight
Dec 1, 2025RBC CapitalDowngradeOutperformSector Perform
Nov 6, 2025BarclaysMaintainedEqual-WeightEqual-Weight
Nov 5, 2025CitigroupMaintainedNeutralNeutral
Nov 5, 2025TD CowenMaintainedHoldHold
Nov 5, 2025RBC CapitalMaintainedOutperformOutperform
Nov 5, 2025Goldman SachsMaintainedSellSell
Nov 5, 2025Wells FargoMaintainedOverweightOverweight